MHM, AMT, Davis Polk, STB acting on chipmaker Kioxia’s $645 mln IPO
Mori Hamada & Matsumoto and Davis Polk & Wardwell are advising Japanese chipmaker Kioxia on its planned 100-billion-yen ($645 million) IPO, with Anderson Mori & Tomotsune and Simpson Thacher & Bartlett representing the international managers.
According to Reuters, the Bain Capital-backed Kioxia is the first company to…
Nishimura guides Goldman Sachs on $530 mln Japan take-private deal
Japanese Big Four firm Nishimura & Asahi has advised global investment bank Goldman Sachs on its acquisition and privatisation via management buyout of Nihon Housing, a building and real estate management company, for $530 million.
SAM, CAM, Hogan Lovells guide Acme Solar’s $343 mln India IPO
Shardul Amarchand Mangaldas & Co has advised Acme Solar, one of India's largest renewable energy independent power producers, on its $343 million initial public offering.
Khaitan, JSA, Hogan Lovells guide $515 mln Waaree IPO
Khaitan & Co has advised Waaree Energies, India's largest manufacturer and exporter of solar modules, on its $515 million initial public offering, with JSA Advocates & Solicitors and Hogan Lovells guiding the bookrunning lead managers.
CAM, Khaitan guide Adani-backed Renew Exim’s $380 mln ITD acquisition
Cyril Amarchand Mangaldas has advised Adani Group's Dubai-based firm Renew Exim DMCC on its acquisition of a 46.64 percent stake in ITD Cementation India for around $380 million from Italian-Thai Development Public Company, who was represented by Khaitan & Co.
Wadia Ghandy, CAM guide StanChart’s $490 mln sale of personal loan business
Wadia Ghandy has guided Kotak Mahindra on its acquisition of Standard Chartered Bank’s personal loan business in India for $490 million, with Cyril Amarchand Mangaldas advising Standard Chartered.
AZB, S&R act on $645 mln Afcons IPO
AZB & Partners is advising Afcons, one of India’s largest international infrastructure construction companies, on its upcoming initial public offering worth $645 million. S&R Associates is acting for the bookrunning lead managers.
CAM, SAM advise on Advent’s $762 mln purchase of India pharma stake
Shardul Amarchand Mangaldas & Co (SAM) has advised private equity major Advent International on the purchase of a 50.1 percent stake in India’s Suven Pharmaceuticals, with Cyril Amarchand Mangaldas (CAM) advising the sellers, the Jasti family.
Cleary, Goodwin advise on Takeda’s $6 bln drug deal
Cleary Gottlieb Steen & Hamilton has advised Japanese pharmaceutical giant Takeda on its planned acquisition of U.S.-based Nimbus Therapeutics' experimental psoriasis drug, with Goodwin Procter acting for the seller.
CC, Links lead on Sunshine Insurance’s $861 mln HK IPO
Clifford Chance has advised Beijing-based Sunshine Insurance Group on its HK$6.7 billion ($861 million) IPO on the Hong Kong Stock Exchange, with Linklaters and King & Wood Mallesons acting for the underwriters.